Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
2.6 USD
-0.38%
Market Closed
Updated:
Apr 28, 2024
Adaptive Biotechnologies Corp
Interest Income Expense
|
Adaptive Biotechnologies Corp
Interest Income Expense Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Interest Income Expense
$1.7m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Interest Income Expense
-$542m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-9%
|
|
|
Danaher Corp
NYSE:DHR
|
Interest Income Expense
-$366m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-11%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Interest Income Expense
-$77.4m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Interest Income Expense
-$24m
|
CAGR 3-Years
28%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Interest Income Expense
-$636m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-18%
|
See Also
What is Adaptive Biotechnologies Corp's Interest Income Expense?
Interest Income Expense
1.7m
USD
1.7m
USD
Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Interest Income Expense amounts to 1.7m USD.
What is Adaptive Biotechnologies Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-12%
-12%
The average annual Interest Income Expense growth rates for Adaptive Biotechnologies Corp have been -36% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
